Terms: = Uterine cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Treatment
41 results:
1. Gestational choriocarcinoma.
Bogani G; Ray-Coquard I; Mutch D; Vergote I; Ramirez PT; Prat J; Concin N; Ngoi NYL; Coleman RL; Enomoto T; Takehara K; Denys H; Lorusso D; Takano M; Sagae S; Wimberger P; Segev Y; Kim SI; Kim JW; Herrera F; Mariani A; Brooks RA; Tan D; Paolini B; Chiappa V; Longo M; Raspagliesi F; Benedetti Panici P; Di Donato V; Caruso G; Colombo N; Pignata S; Zannoni G; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Oct; 33(10):1504-1514. PubMed ID: 37758451
[TBL] [Abstract] [Full Text] [Related]
2. E7050 Suppresses the Growth of Multidrug-Resistant Human uterine Sarcoma by Inhibiting Angiogenesis via Targeting of vegfr2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
3. Resveratrol against Cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
4. The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.
Berger AA; Kawaler EA; Dao F; Misirlioglu S; Fernandez EA; Olvera N; Van Oudenhove E; DeLair D; Levine DA
Gynecol Oncol; 2022 Nov; 167(2):323-333. PubMed ID: 36150916
[TBL] [Abstract] [Full Text] [Related]
5. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical cancer in a Subcutaneous Xenograft Mouse Model.
Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
[TBL] [Abstract] [Full Text] [Related]
6. Significance of HER2 and vegfr2 in Early-stage Endometrial cancer.
An HJ; Song DH; Kim YM; Jo HC; Baek JC; Park JE
In Vivo; 2022; 36(2):723-730. PubMed ID: 35241527
[TBL] [Abstract] [Full Text] [Related]
7. Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
Baeten IGT; Hoogendam JP; Jonges GN; Jürgenliemk-Schulz IM; Braat AJAT; van Diest PJ; Gerestein CG; Zweemer RP
Gynecol Oncol; 2022 May; 165(2):257-263. PubMed ID: 35219527
[TBL] [Abstract] [Full Text] [Related]
8. A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical cancer After Failure of First-Line Therapy.
Yang H; Sun S; Mei Z; Xiang Q; Yang C; Chen M; Xie C; Zhou Y; Qiu H
Drug Des Devel Ther; 2021; 15():4665-4674. PubMed ID: 34815663
[TBL] [Abstract] [Full Text] [Related]
9. Anti-tumour effect of in situ vaccines combined with vegfr inhibitors in the treatment of metastatic cervical cancer.
Liu L; Cai L; Du X; Zhao J; Zhao Y; Zou C; Yu S; Zhang C; Ye P; Su X; Yan X; Li W
Int Immunopharmacol; 2021 Dec; 101(Pt B):108302. PubMed ID: 34717193
[TBL] [Abstract] [Full Text] [Related]
10. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
11. Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway.
Zhang X; Wang Y; Wang X; Zou B; Mei J; Peng X; Wu Z
Cancer Gene Ther; 2021 May; 28(5):529-542. PubMed ID: 33235271
[TBL] [Abstract] [Full Text] [Related]
12. HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Qiu Y; Maione F; Capano S; Meda C; Picconi O; Brundu S; Pisacane A; Sapino A; Palladino C; Barillari G; Monini P; Bussolino F; Ensoli B; Sgadari C; Giraudo E
Mol Cancer Ther; 2020 Dec; 19(12):2476-2489. PubMed ID: 33082275
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Efficacy and Safety of Apatinib for the treatment of Patients with Metastatic, Recurrent Cervical cancer after Failure of Radiotherapy and First-Line Chemotherapy: A Prospective Study.
Xia X; Jiang W; Qi W; Hong B; Zhao W
Oncol Res Treat; 2020; 43(12):649-655. PubMed ID: 33045704
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of Variances in VEGF-A-D and vegfr-1-3 Expression in the Ishikawa Endometrial cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect.
Kras P; Talkowski K; Grabarek BO; Skalska-Dziobek N; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(5):697-705. PubMed ID: 32648839
[TBL] [Abstract] [Full Text] [Related]
15. Cervical cancer patients that respond to chemoradiation therapy display an intense tumor infiltrating immune profile before treatment.
Martins PR; Machado CMT; Coxir SA; de Oliveira AJ; Moreira TB; Campos LS; Alcântara R; de Paula SOC; de Oliveira Salles PG; Gollob KJ; Magalhães WCS
Exp Mol Pathol; 2019 Dec; 111():104314. PubMed ID: 31654628
[TBL] [Abstract] [Full Text] [Related]
16. Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures.
Park I; Shim YS; Go H; Hong BS; Lee JL
BMC Urol; 2019 Jun; 19(1):51. PubMed ID: 31182090
[TBL] [Abstract] [Full Text] [Related]
17. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Makker V; Rasco D; Vogelzang NJ; Brose MS; Cohn AL; Mier J; Di Simone C; Hyman DM; Stepan DE; Dutcus CE; Schmidt EV; Guo M; Sachdev P; Shumaker R; Aghajanian C; Taylor M
Lancet Oncol; 2019 May; 20(5):711-718. PubMed ID: 30922731
[TBL] [Abstract] [Full Text] [Related]
18. Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium.
Kolanska K; Varinot J; Canlorbe G; Bergeron C; Mekinian A; Capmas P; Koskas M; Daraï E; Aractingi S; Bendifallah S; Chabbert-Buffet N
Reprod Biomed Online; 2019 May; 38(5):825-834. PubMed ID: 30898512
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis.
Kfouri CFDA; Lombardi W; Romania MCFN; Puls ML; Martins-Ferreira RA; Lombardi LB; Andrade JM
Rev Col Bras Cir; 2019 Feb; 46(1):e2077. PubMed ID: 30785571
[TBL] [Abstract] [Full Text] [Related]
20. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract] [Full Text] [Related]
[Next]
